Upadhyay, R.; Klamer, B.; Matsui, J.; Chakravarthy, V.B.; Scharschmidt, T.; Yeager, N.; Setty, B.A.; Cripe, T.P.; Roberts, R.D.; Aldrink, J.H.;
et al. Disease Control and Toxicity Outcomes after Stereotactic Ablative Radiation Therapy for Recurrent and/or Metastatic Cancers in Young-Adult and Pediatric Patients. Cancers 2024, 16, 2090.
https://doi.org/10.3390/cancers16112090
AMA Style
Upadhyay R, Klamer B, Matsui J, Chakravarthy VB, Scharschmidt T, Yeager N, Setty BA, Cripe TP, Roberts RD, Aldrink JH,
et al. Disease Control and Toxicity Outcomes after Stereotactic Ablative Radiation Therapy for Recurrent and/or Metastatic Cancers in Young-Adult and Pediatric Patients. Cancers. 2024; 16(11):2090.
https://doi.org/10.3390/cancers16112090
Chicago/Turabian Style
Upadhyay, Rituraj, Brett Klamer, Jennifer Matsui, Vikram B. Chakravarthy, Thomas Scharschmidt, Nicholas Yeager, Bhuvana A. Setty, Timothy P. Cripe, Ryan D. Roberts, Jennifer H. Aldrink,
and et al. 2024. "Disease Control and Toxicity Outcomes after Stereotactic Ablative Radiation Therapy for Recurrent and/or Metastatic Cancers in Young-Adult and Pediatric Patients" Cancers 16, no. 11: 2090.
https://doi.org/10.3390/cancers16112090
APA Style
Upadhyay, R., Klamer, B., Matsui, J., Chakravarthy, V. B., Scharschmidt, T., Yeager, N., Setty, B. A., Cripe, T. P., Roberts, R. D., Aldrink, J. H., Singh, R., Raval, R. R., Palmer, J. D., & Baliga, S.
(2024). Disease Control and Toxicity Outcomes after Stereotactic Ablative Radiation Therapy for Recurrent and/or Metastatic Cancers in Young-Adult and Pediatric Patients. Cancers, 16(11), 2090.
https://doi.org/10.3390/cancers16112090
